Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Hepatitis C

Interventions

DRUG

BI 201335

Relevant treatment dose capsule (A) for oral administration

DRUG

BI 201335

Relevant treatment dose capsule (B) for oral administration

Trial Locations (1)

1220.58.1 Boehringer Ingelheim Investigational Site, Kiel